BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1992985)

  • 61. Ploidy levels in nonneoplastic and neoplastic thyroid cells.
    Auer GU; Bäckdahl M; Forsslund GM; Askensten UG
    Anal Quant Cytol Histol; 1985 Jun; 7(2):97-106. PubMed ID: 4026949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Papillary thyroid carcinoma: an overview.
    Al-Brahim N; Asa SL
    Arch Pathol Lab Med; 2006 Jul; 130(7):1057-62. PubMed ID: 16831036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Initial results of image cytometric DNA analysis in the evaluation of prognosis in papillary thyroid cancer].
    Böttger T; Gabbert H; Stöckle M; Schernos B; Junginger T
    Langenbecks Arch Chir; 1991; 376(3):158-62. PubMed ID: 1870365
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.
    Hamming JF; Schelfhout LJ; Cornelisse CJ; van de Velde CJ; Goslings BM; Hermans J; Fleuren GJ
    World J Surg; 1988 Aug; 12(4):503-8. PubMed ID: 3420932
    [No Abstract]   [Full Text] [Related]  

  • 65. Are the morphology of papillary thyroid carcinoma and the tumour's behaviour correlated?
    Hefer T; Joachims HZ; Eitan A; Munichor M
    J Laryngol Otol; 1996 Jul; 110(7):704-5. PubMed ID: 8759556
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors.
    Bibbo M; Bartels PH; Galera-Davidson H; Dytch HE; Wied GL
    Anal Quant Cytol Histol; 1986 Jun; 8(2):168-76. PubMed ID: 2425826
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland. A nationwide study in Iceland on carcinomas diagnosed 1955-1990.
    Jónasson JG; Hrafnkelsson J
    Virchows Arch; 1994; 425(4):349-55. PubMed ID: 7820299
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carcinoma of the thyroid at a young age--a review of 23 patients.
    Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Noguchi M; Matsubara F; Watanabe K
    Histopathology; 1992 Jan; 20(1):63-6. PubMed ID: 1737627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Papillary carcinoma tall cell variant (TCV): a review.
    LiVolsi VA
    Endocr Pathol; 2010 Mar; 21(1):12-5. PubMed ID: 20174895
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.
    Cartwright S; Fingeret A
    Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):351-357. PubMed ID: 32701516
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Breast Tumours Resembling the Tall Cell Variant of Thyroid Papillary Carcinoma: Are They Part of the Papillary Carcinoma Spectrum or a Distinct Entity?
    Toss MS; Billingham K; Egbuniwe IU; Moreno F; Abass A; Rakha EA
    Pathobiology; 2019; 86(2-3):83-91. PubMed ID: 30308500
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Cytofluorometric DNA analysis in different histological patterns of thyroid papillary carcinoma].
    Saka T; Yamamoto Y; Itoh T; Inoue I; Imanaka M; Okato H; Takahashi H
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Jun; 97(6):1034-40. PubMed ID: 8051591
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of flow cytometry with static densitometry in papillary thyroid carcinoma.
    Cusick EL; MacIntosh CA; Krukowski ZH; Ewen SW; Matheson NA
    Br J Surg; 1990 Aug; 77(8):913-6. PubMed ID: 2393818
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Automated analysis of rat breast tumors. Comparison of four methods.
    Wachtel MS; Zahniser DJ; Rogers AE; Hutchinson ML
    Anal Quant Cytol Histol; 1991 Feb; 13(1):69-73. PubMed ID: 2025376
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Papillary carcinoma of the thyroid, oxyphil cell type, "clear cell" variant: a light- and electron-microscopic study.
    Dickersin GR; Vickery AL; Smith SB
    Am J Surg Pathol; 1980 Oct; 4(5):501-9. PubMed ID: 7435777
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Carcinoma of the thyroid with the so-called "tall cells"].
    Macák J
    Cesk Patol; 1993 Feb; 29(1):9-10. PubMed ID: 8485782
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells.
    Wallin G; Bäckdahl M; Christensson B; Grimelius L; Auer G
    Anal Quant Cytol Histol; 1992 Aug; 14(4):296-303. PubMed ID: 1388566
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nuclear DNA content of occult sclerosing and frank papillary carcinoma of the thyroid.
    Izuo M; Okagaki T; Richart RM; Lattes R
    Cancer; 1971 Apr; 27(4):902-9. PubMed ID: 4929938
    [No Abstract]   [Full Text] [Related]  

  • 79. [DNA concentrations in the nuclei of unaltered follicular epithelium in follicular adenomas and thyroid cancer].
    Tarasov SS
    Probl Endokrinol (Mosk); 1983; 29(4):79-81. PubMed ID: 6889306
    [No Abstract]   [Full Text] [Related]  

  • 80. A morphometric study of nuclei, nucleoli and nuclear bodies in goitres and papillary thyroid carcinomas.
    Sobrinho-Simões MA; Gonçalves V; Sousa-Lé F; Cardoso V
    Experientia; 1977 Dec; 33(12):1642-3. PubMed ID: 590463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.